Search company, investor...


Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$7.1M | 12 yrs ago

About Celecure

Celecure AS does drug discovery and development of anticancer drugs. Celecure is the R&D unit of Celecure Group, an estonian biotech company.

Headquarters Location

Celecure AS Akadeemia 15



Missing: Celecure's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Celecure's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Celecure

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Celecure is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

838 items

Celecure Frequently Asked Questions (FAQ)

  • When was Celecure founded?

    Celecure was founded in 2002.

  • What is Celecure's latest funding round?

    Celecure's latest funding round is Unattributed VC.

  • How much did Celecure raise?

    Celecure raised a total of $9.32M.

  • Who are the investors of Celecure?

    Investors of Celecure include Hadasit Bio Holdings, Ambient Sound Investments and Enterprise Estonia.

  • Who are Celecure's competitors?

    Competitors of Celecure include Metabolon, Visiopharm, Heptares Therapeutics, Blue Sky BioServices, EpiTherapeutics and 10 more.

Compare Celecure to Competitors

Metabolon Logo

Metabolon is a health technology company focused on metabolomics. It offers a tool for precision medicine and life sciences research. The company's platforms and informatics deliver biomarker discoveries, diagnostic tests, and partnerships in genomics-based, health initiatives. Metabolon was founded in 2000 and is based in Morrisville, North Carolina.

Heptares Therapeutics

Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors (GPCRs). Heptares StaR (Stabilized Receptor) technology enables thermo-stabilization of GPCRs, a breakthrough allowing X-ray crystallography of conformationally-constrained receptors, thereby facilitating structure-based drug design at GPCRs that have been resistant to traditional methods of drug screening.

Visiopharm Logo

Visiopharm is a provider of quantitative image analysis software and end-to-end Digital Pathology solutions for Hospitals, biopharmaceutical companies, and research institutions around the world. Products include ONCOTOPIX Diagnostics, a robust solution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and VirtualDoubleStaining.


Novadrug is a drug discovery company geared toward the identification of effective antimicrobial, antiviral, immunosuppressive and anticancer drugs.


Xention is a Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs. The Company has potential breakthrough drugs for atrial fibrillation, an area in which it has developed considerable expertise.

Trana Discovery Logo
Trana Discovery

Trana Discovery, a drug discovery technology company, aims to help its partners find classes of drugs for the treatment of serious viral, fungal, and bacterial infectious diseases. The technology identifies compounds that work through a mechanism of action: inhibition of the target pathogen's ability to use transfer RNA (tRNA) essential for protein synthesis or replication. The use of Trana Discovery technology can unlock the value " scientific, human, and financial " hidden in drug compound libraries, expedite the discovery of drugs, and provide opportunities for exclusive rights to drug classes.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.